Role of intestinal bacteria in gliadin-induced changes in intestinal mucosa: study in germ-free rats.
OBJECTIVE
Celiac disease (CD) is a chronic inflammatory disorder of the small intestine that is induced by dietary wheat gluten proteins (gliadins) in genetically predisposed individuals. The overgrowth of potentially pathogenic bacteria and infections has been suggested to contribute to CD pathogenesis. We aimed to study the effects of gliadin and various intestinal bacterial strains on mucosal barrier integrity, gliadin translocation, and cytokine production.


RESULTS
Changes in gut mucosa were assessed in the intestinal loops of inbred Wistar-AVN rats that were reared under germ-free conditions in the presence of various intestinal bacteria (enterobacteria and bifidobacteria isolated from CD patients and healthy children, respectively) and CD-triggering agents (gliadin and IFN-γ) by histology, scanning electron microscopy, immunofluorescence, and a rat cytokine antibody array. Adhesion of the bacterial strains to the IEC-6 rat cell line was evaluated in vitro. Gliadin fragments alone or together with the proinflammatory cytokine interferon (IFN)-γ significantly decreased the number of goblet cells in the small intestine; this effect was more pronounced in the presence of Escherichia coli CBL2 and Shigella CBD8. Shigella CBD8 and IFN-γ induced the highest mucin secretion and greatest impairment in tight junctions and, consequently, translocation of gliadin fragments into the lamina propria. Shigella CBD8 and E. coli CBL2 strongly adhered to IEC-6 epithelial cells. The number of goblet cells in small intestine increased by the simultaneous incubation of Bifidobacterium bifidum IATA-ES2 with gliadin, IFN-γ and enterobacteria. B. bifidum IATA-ES2 also enhanced the production of chemotactic factors and inhibitors of metalloproteinases, which can contribute to gut mucosal protection.


CONCLUSIONS
Our results suggest that the composition of the intestinal microbiota affects the permeability of the intestinal mucosa and, consequently, could be involved in the early stages of CD pathogenesis.
Department of Immunology, Institute of Microbiology v.v.i., Academy of Sciences of the Czech Republic, Prague, Czech Republic. Cinova7@seznam.cz
Jana
J
Cinova
Giada
G
De Palma
Renata
R
Stepankova
Olga
O
Kofronova
Miloslav
M
Kverka
Yolanda
Y
Sanz
Ludmila
L
Tuckova
D000818:Animals; D001419:Bacteria / Q000472:pathogenicity*; D001427:Bacterial Toxins / Q000494:pharmacology; D001644:Bifidobacterium / Q000472:pathogenicity; D002446:Celiac Disease / Q000209:etiology; D016207:Cytokines / Q000096:biosynthesis; D004755:Enterobacteriaceae / Q000472:pathogenicity; D005856:Germ-Free Life; D005903:Gliadin / Q000493:pharmacokinetics* / Q000494:pharmacology; D020397:Goblet Cells / Q000473:pathology; D054884:Host-Pathogen Interactions / Q000187:drug effects; D007371:Interferon-gamma / Q000494:pharmacology; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000378:metabolism / Q000382:microbiology*; D007422:Intestines / Q000382:microbiology / Q000473:pathology; D010539:Permeability; D051381:Rats
D001427:Bacterial Toxins; D016207:Cytokines; D007371:Interferon-gamma; D005903:Gliadin
Gut. 2008 Jul;57(7):887-92
17965065
Clin Exp Immunol. 2007 Dec;150(3):531-8
17956582
Clin Exp Immunol. 2008 Aug;153(2):162-73
18713140
Mediators Inflamm. 2005 Dec 14;2005(6):373-9
16489258
Gastroenterology. 2005 Nov;129(5):1400-13
16285941
PLoS One. 2007 Dec 12;2(12):e1308
18074031
Clin Exp Immunol. 2008 Jun;152(3):552-8
18422736
Science. 1996 Sep 6;273(5280):1380-3
8703071
BMC Gastroenterol. 2008 Nov 04;8:50
18983674
J Leukoc Biol. 2010 May;87(5):765-78
20007908
Curr Microbiol. 2008 Jun;56(6):613-8
18330633
J Innate Immun. 2009;1(2):123-35
20375571
J Med Microbiol. 2007 Dec;56(Pt 12):1669-1674
18033837
BMC Microbiol. 2008 Dec 22;8:232
19102766
J Exp Med. 1989 Jan 1;169(1):345-50
2909659
J Clin Immunol. 2007 Mar;27(2):201-9
17260166
Gastroenterology. 1992 Jan;102(1):330-54
1727768
Am J Clin Nutr. 2001 Jun;73(6):1131S-1141S
11393191
Gut. 1995 Feb;36(2):209-14
7883219
J Leukoc Biol. 2000 Mar;67(3):312-8
10733090
Scand J Gastroenterol. 1996 Sep;31(9):868-74
8888433
Am J Gastroenterol. 2004 May;99(5):894-904
15128357
Ann N Y Acad Sci. 2009 May;1165:195-205
19538307
Scand J Gastroenterol. 1996 Jun;31(6):551-7
8789893
Gut. 2008 Jul;57(7):879-81
18559381
Folia Microbiol (Praha). 2008;53(3):214-6
18661294
Gastroenterology. 2003 Oct;125(4):1105-13
14517794
Acta Paediatr. 1997 Sep;86(9):956-61
9343275
Gut. 2000 Feb;46(2):218-24
10644316
Histochemistry. 1988;88(2):105-12
2450078
Am J Clin Pathol. 2006 Apr;125(4):502-11
16627260
Gastroenterology. 1994 Feb;106(2):533-9
8299918
Gut. 1989 Oct;30(10):1339-43
2583562
Gut. 2002 Oct;51(4):540-7
12235077
Curr Issues Intest Microbiol. 2007 Mar;8(1):9-14
17489434
J Clin Pathol. 2009 Mar;62(3):264-9
18996905
Biochem J. 2004 Oct 15;383(Pt 2):311-8
15245330
J Immunol. 2005 Nov 15;175(10):7038-45
16272365
Microbiol Mol Biol Rev. 1997 Jun;61(2):136-69
9184008
Neurochem Int. 2009 Sep;55(5):275-81
19576514
J Exp Anim Sci. 1992 Dec;35(3):110-9
1295576
Dig Dis Sci. 1995 Dec;40(12):2532-9
8536508
Int Arch Allergy Immunol. 2002 Jun;128(2):77-89
12065907
Clin Chem. 2007 May;53(5):955-62
17363422
Scand J Gastroenterol. 2006 Apr;41(4):408-19
16635908
Cell Host Microbe. 2007 Nov 15;2(5):328-39
18005754
Gut. 1999 Jan;44(1):17-25
9862821
Folia Microbiol (Praha). 1979;24(1):11-5
571394
FEBS Lett. 2005 Aug 29;579(21):4851-5
16099460
Nat Med. 1997 Jul;3(7):797-801
9212111
Gastroenterology. 2009 Dec;137(6):1912-33
19766641
Hum Immunol. 2006 Jun;67(6):460-8
16728270
Nat Genet. 2007 Jul;39(7):827-9
17558408
Exp Anim. 1996 Apr;45(2):155-60
8726140
Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16799-804
19805376